Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextenza vs Prednisolone Acetate after Cataract Surgery
NCT05665270Phase 4Unknown
- Sponsor
- Wyse Eyecare
- Start
- Jan 2023
- Primary completion
- Oct 2023
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ozurdex in post-operative inflammation, postoperative pain, sponsored by Wyse Eyecare. Status: unknown.
02
Drugs
ozurdex
03
Conditions
post-operative inflammationpostoperative pain
Beyond the preview
Go deeper on NCT05665270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05665270.